Navigation Links
Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals
Date:3/7/2013

SAN DIEGO, March 7, 2013 /PRNewswire/ -- Receptos, a biopharmaceutical company focused on developing therapeutic candidates directed to G-protein-coupled receptor (GPCR) targets, announced today that it has successfully determined a novel protein crystal structure of an undisclosed proprietary GPCR drug discovery target for Ono Pharmaceuticals.

In December 2011, Ono entered into a technology collaboration to access Receptos' proprietary GPCR structure determination technology platform, which enables rational drug design for the GPCR target class. The structure determination milestone represents the third significant milestone met under the terms of the collaboration, all of which have been achieved ahead of originally anticipated timelines. Financial terms were not disclosed.

"The timely delivery of a novel GPCR structure under the Ono-Receptos collaboration supports structure-based drug design efforts at Ono for an important therapeutic target," said Faheem Hasnain , President and Chief Executive Officer of Receptos. "This rapid success represents further endorsement of the robust nature of the Receptos GPCR structural biology expertise that underpins our proprietary platform technology."

"The novel GPCR structure determined through the collaboration will greatly accelerate our structure-based drug design," said Kazuhito Kawabata , Ph.D., Members of the Board of Directors, Executive Officer and Executive Director, Discovery and Research of Ono. "We have high regard for the Receptos' GPCR protein crystallization platform technology and recognize its potential to strengthen our drug discovery capabilities.  We are pleased to contribute to society through innovative drug discovery that can fulfill unmet medical needs."

The Ono collaboration milestone achievement builds on Receptos' exceptional track record for successful crystallography and s
'/>"/>

SOURCE Receptos
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Graham Cooper Appointed Chief Financial Officer of Receptos
2. Receptos to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference
3. Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
4. Frost & Sullivan Determines a Real and Urgent Need for Novel Cancer Diagnostics Tests
5. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
6. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
7. Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102
8. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
9. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
10. Novelos Therapeutics Prices $5.5 Million Public Offering
11. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- Inc. ... Inc. for the third straight year, No. 349 ... an exclusive ranking of the nation,s fastest-growing private ... at the most important segment of the economy—America,s ... Dell, Domino,s Pizza, LinkedIn, Zillow, and many other ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
(Date:8/21/2014)... , Aug. 21, 2014  AliveCor, ... and Drug Administration (FDA) has granted the ... atrial fibrillation (AFib), the most common form ... (algorithm) instantly detects if patients are experiencing ... on the mobile phone based AliveCor® Heart ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device 2
... 2011 EMKinetics, Inc. announced today initiation of ... trial for patients suffering from urge incontinence and ... at 10-15 US centers.  Submission for CE mark ... the study.   EMKinetics, TranStim therapy builds on ...
... 2011 Masimo (NASDAQ: MASI ) announced ... period ended October 1, 2011, after the market closes on October ... at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted ... de Raad, Executive Vice President and Chief Financial Officer. ...
Cached Medicine Technology:EMKinetics Announces Start of Pivotal Trial for the TranStim™ Transdermal Neuromodulation System 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 2Masimo to Report Third Quarter 2011 Financial Results After Market Close on October 25, 2011 3
(Date:8/22/2014)... August 22, 2014 Mi40x , the ... research to show people how they can use a simple ... only a matter of weeks has caught the attention of ... is one of the most well-known bodybuilders in the industry, ... he has today, that in itself is a testament to ...
(Date:8/22/2014)... (EGFR) mutations found in the circulating free tumor DNA ... cancer (NSCLC) patients correlates well with the EGFR mutations ... inhibitor (TKI) therapy is approved for EGFR activating mutation ... determining mutation status is with DNA derived directly from ... A more abundant and less invasive source of tumor ...
(Date:8/22/2014)... Restore My Vision Today , ... Pearson to help people discover how they can get ... by instead improving their eyesight naturally has caught the ... , “There’s a reason why the glasses and contacts ... because people just assume that it’s their only option ...
(Date:8/22/2014)... Eagerly embracing intended parents around the globe, ... offers the top male infertility programs — run by ... network of IVFinMexico.com continues to shape modern ... female and male infertility, advanced research and education. , ... eminently set by company CEO and Founder Tolga Umar ...
(Date:8/22/2014)... 22, 2014 The improved access to ... in the developing world, has led to the decline ... of deaths due to AIDS globally. However, despite the ... of new patients becoming affected by the virus is ... undertaken by all related organisations and stakeholders, by 2015, ...
Breaking Medicine News(10 mins):Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3
... 1 Misonix, Inc., (Nasdaq: MSON ), a ... Europe is used for the ablation of tumors and worldwide ... of its direct sales channel for the United States, which ... already established, commission based, contract sales organization, the Company has ...
... , KNOXVILLE, Tenn., Sept. ... Joint Commission,s intra-cycle certification, a program that offers an ... provide competent staffing services. This certification follows Spectrum,s third ... in 2008. , , "Healthcare organizations ...
... , , , ... sixth season of the Thrive advertising campaign, with television, radio, print ... the total health of its members and the communities it serves. ... and "Connected" -- illustrate Kaiser Permanente,s leadership in leveraging health information ...
... , PORTLAND, Ore., Sept. 1 ... Award recognizing the Administrator software for its innovative contributions to Senior ... Awards Program is the first awards program of its kind to ... families and care providers. Entries were judged by a distinguished panel ...
... , , HOUSTON, Sept. 1 ... is the first hospital in Houston to feature the CyberKnife((R)), a ... tumors. , , The CyberKnife((R)) is the world,s ... of high-dose radiation with extreme accuracy throughout the body, including the brain, ...
... Medicaid Savings Could Surpass $59 Billion , , ... to reach an additional 20 million patients as part of national health ... the ten-year period 2010 to 2019, including federal Medicaid savings of $59 ... of the health center investment of $38.8 billion called for in the ...
Cached Medicine News:Health News:Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States 2Health News:Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States 3Health News:Joint Commission Recognizes Spectrum Healthcare Resources 2Health News:Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 2Health News:Kaiser Permanente Debuts New Ads Focused on Technology and Innovation 3Health News:Vigilan Earns Honor in the 2009 Product & Technology Awards Program by Mature Market Resource Center 2Health News:St. Luke's Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 2Health News:St. Luke's Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 3Health News:Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade 2Health News:Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade 3
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Protein A - 50 OD...
Colloidal Gold Conjugated, Protein A - 12 OD...
Medicine Products: